CD40 ligand and tdTomato-armed vaccinia virus for induction of antitumor immune response and tumor imaging
Suvi Parviainen(University of Helsinki), Vincenzo Cerullo(University of Helsinki)
Cited by 42
Related Papers
Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids
|Journal for ImmunoTherapy of Cancer|2021|53
Enhancing T-cell recruitment in renal cell carcinoma with cytokine-armed adenoviruses
|OncoImmunology|2024|11
Low-dose decitabine enhances the efficacy of viral cancer vaccines for immunotherapy
|Molecular Therapy Oncology|2024|6
Leveraging glucan-induced trained immunity for the epigenetic and metabolic rewiring of macrophages to enhance colorectal cancer vaccine response
|Nature Communications|2026|4
DEVELOPING GENETICALLY ENGINEERED ONCOLYTIC VIRUSES FOR CANCER GENE THERAPY
|Työväentutkimus Vuosikirja|2015|0